ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...

Cabenuva is administered every two months and was offered to patients who achieved viral suppression from daily treatments.

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

Experts have proposed new treatment modes for older people with HIV. The new treatment does not cause the health-threatening ...

Aug. 8, 2023 — Some HIV-1 carriers who have received an early antiretroviral treatment during several years are able to control the virus for a long term after treatment interruption. However ...

Centre for Epidemiological Modelling and Analysis (CEMA), have released results of three studies that could significantly ...

Acquired immune deficiency syndrome, or AIDS, caused by the human immunodeficiency virus (HIV), weakens the body's immune ...

A Case Western Reserve University School of Medicine researcher has received a $2.5 million grant from Gilead Sciences, a California-based biopharmaceutical company, to see if two so-far ...

Sofosbuvir, a hepatitis C treatment drug, can adversely interact with tenofovir disoproxil, a HIV treatment drug, according to research led by Bingfang Yan, PhD, professor of biomedical and ...

A single dose of an antibody-based treatment can prevent human immunodeficiency virus (HIV) transmission from mother to baby, according to new nonhuman primate research. The findings (“Single ...